Noncompliant patients or those not receiving treatment despite being assigned to treatment group must be analyzed according to their initial random assignment.

Excluding noncompliant patients from the analysis or analyzing them as if they were in the control group destroys the unbiased comparison provided by randomization.

Noncompliant patients often have worse outcomes (or better) due to factors other than treatment that affect prognosis.